Prometrium Cost in Illinois 2026: Cash Price, Insurance, Medicaid and Compounded Options

What Does Prometrium Actually Cost in Illinois Right Now?

Prometrium's manufacturer list price sits at $180 per month in 2026, but almost no one in Illinois pays that figure out of pocket. The average cash-pay price across Illinois retail chains and independent pharmacies is approximately $45 per month when you use a discount card or generic substitution. Compounded micronized progesterone from a licensed 503A pharmacy drops that floor to roughly $25 per month.

List Price vs. Real-World Cash Price

The $180 figure is the wholesale acquisition cost set by AbbVie (which markets Prometrium after acquiring Solvay Pharmaceuticals). Retail pharmacy markup and pharmacy benefit manager spread can push the sticker price at the counter higher than that. Discount platforms such as GoodRx, RxSaver, and Cost Plus Drugs index directly against pharmacy acquisition cost and strip out most of that markup.

Micronized progesterone is the active ingredient in Prometrium, and FDA-approved generics entered the U.S. Market years ago. Generic micronized progesterone capsules carry the same bioequivalence data as the brand and are typically priced 60 to 80% below the brand list price at Illinois chain pharmacies. The FDA's Orange Book confirms therapeutic equivalence for approved generics, which means your pharmacist can substitute automatically unless the prescriber writes "dispense as written."

Why Price Varies Across Illinois Pharmacies

Chain pharmacies (CVS, Walgreens, Walmart, Costco) negotiate different contracts and may price the same 30-capsule quantity anywhere from $38 to $90 before a coupon. Independent compounding pharmacies operate on a cost-plus model and price closer to the $25, $35 range. Rural Illinois counties with fewer competing pharmacies tend to show higher cash prices, while Chicago-area pharmacies see more price competition.

A 2022 JAMA Internal Medicine analysis found that prescription drug prices vary by more than 10-fold for the same drug across U.S. Pharmacies, a pattern that applies directly to progesterone in Illinois.

The Clinical Rationale for Micronized Progesterone

Understanding why this drug is prescribed helps explain why dose, duration, and formulation matter to cost.

What the PEPI Trial Established

The landmark Postmenopausal Estrogen/Progestin Interventions (PEPI) trial, published in JAMA in 1995 (N=875), compared conjugated equine estrogen alone against four combination regimens over 3 years. The PEPI investigators found that micronized progesterone 200 mg/day (cyclic) preserved the HDL-cholesterol benefit of estrogen better than medroxyprogesterone acetate, a finding that shaped decades of HRT prescribing. That biological distinction is one reason many clinicians specifically request micronized progesterone rather than synthetic progestins.

Approved Indications and Dose Forms

The FDA approves Prometrium in two indications: (1) prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving conjugated estrogens, and (2) secondary amenorrhea. The full FDA prescribing label lists the standard endometrial-protection dose as 200 mg orally once daily at bedtime for 12 days per 28-day cycle, or 100 mg nightly continuously when used with daily estrogen.

A 2019 review in Menopause (the official journal of The Menopause Society) concluded that oral micronized progesterone shows a more favorable safety signal for breast tissue and cardiovascular endpoints than synthetic progestins, though the authors noted the evidence base from randomized trials is thinner than for medroxyprogesterone acetate.

Peanut Oil Allergy Warning

Prometrium capsules are formulated in peanut oil. Patients with a documented peanut allergy cannot use the brand or most generic capsule formulations. The FDA label carries a contraindication for patients with known peanut allergy. Compounded aqueous or oil-free preparations from a 503A pharmacy may be the only oral option for those patients, which is a legitimate medical reason to pursue compounding beyond price savings alone.

Illinois Medicaid Coverage for Prometrium

Illinois Medicaid (administered through HFS, the Illinois Department of Healthcare and Family Services) covers Prometrium and its generic equivalents on the state formulary, but prior authorization (PA) is required.

Prior Authorization Criteria in Illinois Medicaid

The PA process for micronized progesterone under Illinois Medicaid generally requires documentation of: (1) an estrogen-containing HRT prescription in the same patient, (2) an intact uterus confirmed in the clinical notes, and (3) the prescriber's attestation that the drug is medically necessary. Approval turnaround typically runs 3 to 5 business days through the standard HFS portal, though urgent PA requests can be processed within 24 hours.

Illinois HFS publishes its current preferred drug list and PA criteria at hfs.illinois.gov, and clinicians should confirm current tier placement before writing the prescription, as the formulary updates quarterly.

What Medicaid Beneficiaries Pay After Approval

Once PA is approved, Illinois Medicaid beneficiaries pay a nominal co-pay of $1, $4 per fill depending on their managed care organization (MCO). The state contracts with several Medicaid MCOs including Meridian, Molina, and Blue Cross Community Health Plans, each of which may have slightly different formulary tiers for generic micronized progesterone vs. Brand Prometrium. Generic substitution almost always applies, dropping the member cost to the $1, $2 tier.

The Centers for Medicare and Medicaid Services Medicaid drug rebate program requires manufacturers to rebate the government for covered outpatient drugs, which is part of why Medicaid net cost is far below cash-pay retail.

Commercial Insurance Coverage in Illinois

Most commercial plans sold on the Illinois Exchange and employer-sponsored plans cover micronized progesterone, though tier placement, formulary status, and step-therapy requirements vary.

Formulary Tiers and Step Therapy

Illinois Blue Cross Blue Shield PPO plans typically place generic micronized progesterone on Tier 1 or Tier 2, generating a $10, $40 copay per fill. United Healthcare and Aetna plans in Illinois often place brand Prometrium on Tier 3 (preferred brand), resulting in $50, $90 copays, while generic sits on Tier 1. Some plans require a 90-day supply through mail order to access the lowest tier copay.

Step therapy (fail-first) requirements occasionally mandate a trial of medroxyprogesterone acetate before approving micronized progesterone coverage, particularly on Medicaid MCO plans. If your prescriber documents a clinical reason to avoid synthetic progestins (peanut allergy, prior intolerance, or the prescriber's clinical judgment based on the PEPI data), most Illinois insurers accept that as grounds for a medical exception. The American College of Obstetricians and Gynecologists' guidance on menopause management notes that progestogen selection should be individualized.

Checking Your Specific Plan

The fastest way to verify coverage is the formulary lookup tool on your insurer's member portal. Search for "micronized progesterone" rather than "Prometrium" to capture both brand and generic entries. If the drug does not appear, call the pharmacy benefits line and request a formulary exception. Illinois mandates that insurers respond to non-urgent formulary exception requests within 72 hours under state insurance law.

The Illinois Department of Insurance provides a consumer guide to prescription drug appeals at insurance.illinois.gov.

The AbbVie / Solvay Savings Card Program

AbbVie operates a copay savings card for Prometrium that can reduce out-of-pocket costs for commercially insured patients in Illinois.

Eligibility Rules

The card is available to patients with commercial insurance only. It does not apply to Illinois Medicaid, Medicare Part D, or any other federal or state government-funded plan. Patients must be U.S. Residents, and AbbVie may impose an annual savings cap (historically $3,600, $4,800 per year). The card cannot be used if the drug is not covered by the patient's commercial plan.

AbbVie's patient assistance programs are described on the AbbVie website and through the manufacturer's myAbbVie Assist program. Patients without any insurance coverage who meet income criteria may qualify for free drug through this program rather than the copay card.

How Much It Actually Saves in Illinois

For a commercially insured Illinois patient whose plan places brand Prometrium at a $75 monthly copay, the savings card typically reduces that to $0, $15 per fill. Generic micronized progesterone is already cheap enough at Tier 1 that the savings card adds little value unless the prescriber specifically writes for the brand.

Compounded Micronized Progesterone in Illinois: Legality and Costs

Compounding is legal in Illinois and used routinely for patients who cannot tolerate standard capsule formulations or need non-standard doses.

503A Pharmacy Framework

Under federal law (21 U.S.C. 503A), a licensed 503A compounding pharmacy may prepare micronized progesterone on a patient-specific, prescription basis without FDA pre-approval, provided the pharmacy is licensed by the Illinois Department of Financial and Professional Regulation (IDFPR) and follows USP <795> and USP <797> standards for non-sterile and sterile preparations respectively. The FDA's guidance on 503A compounding outlines the conditions under which these pharmacies may operate.

Illinois does not restrict compounding of micronized progesterone specifically. The IDFPR licenses compounding pharmacies and conducts inspections. USP Chapter <795> sets standards for non-sterile pharmaceutical compounding, and any Illinois 503A pharmacy must comply with those standards to maintain licensure.

What Compounded Progesterone Costs in Illinois

A 30-day supply of compounded micronized progesterone 100 mg capsules from a licensed Illinois 503A pharmacy runs approximately $25, $35 per month in 2026, compared to $45 for retail generic and $180 for brand Prometrium. Troches (buccal dissolving tablets), sublingual drops, and topical cream formulations are also available and typically priced in the $30, $50 range depending on the base and dose.

A 2020 analysis in JAMA Internal Medicine examining compounded hormone therapy found wide variability in quality across compounding pharmacies, underscoring the importance of choosing a pharmacy with current PCAB (Pharmacy Compounding Accreditation Board) accreditation or a strong state inspection record. PCAB accreditation is voluntary but signals a higher quality standard.

Is Compounded Progesterone Clinically Equivalent?

Compounded micronized progesterone is NOT FDA-approved, and no bioequivalence data exist for specific compounded preparations. The Endocrine Society's 2020 position statement on compounded hormone therapy states that compounded hormones should not be used when an FDA-approved product is available unless a specific clinical need exists. The position statement also notes: "Patients should be counseled that compounded preparations have not been evaluated for safety, efficacy, or purity by the FDA."

For most Illinois patients, the FDA-approved generic is the preferred choice. Compounding is best reserved for documented peanut allergy, need for a non-standard dose, or inability to tolerate the standard capsule form.

Telehealth Prescribing of Prometrium in Illinois

Prometrium can be prescribed via telehealth in Illinois. State law does not require an in-person exam before prescribing hormones for menopausal management.

Illinois Telehealth Rules for HRT

Illinois adopted permanent telehealth parity legislation under Public Act 102-0775, which requires commercial insurers to reimburse telehealth visits at parity with in-person visits. The Illinois Telehealth Act is summarized by the Illinois General Assembly. A prescriber conducting an audio-video visit may write a Prometrium prescription, which can then be sent electronically to any Illinois-licensed pharmacy or to a mail-order pharmacy.

The American Telemedicine Association notes that synchronous audio-video visits meet the standard of care for prescription of non-controlled hormonal medications. Prometrium is not a controlled substance, so DEA in-person examination requirements do not apply.

HealthRX Telehealth and Prometrium in Illinois

HealthRX prescribes micronized progesterone as part of individualized HRT protocols for Illinois patients. Our clinical team reviews lab work (serum progesterone, estradiol, FSH, and relevant metabolic markers) before initiating treatment. Illinois patients seen via HealthRX telehealth can receive a Prometrium or generic micronized progesterone prescription sent directly to their preferred Illinois pharmacy or via a mail-order pharmacy. Average time from first visit to prescription transmitted is under 48 hours for established patients with recent labs on file.

The Cheapest Way to Get Prometrium in Illinois in 2026

Cost reduction follows a hierarchy. Here is the order of options from lowest to highest typical out-of-pocket cost for an Illinois patient in 2026.

Step-by-Step Cost-Reduction Framework

Step 1. Ask for the generic first. Generic micronized progesterone 100 mg capsules are bioequivalent to Prometrium and cost roughly $38, $50/month cash at Illinois chain pharmacies without any coupon.

Step 2. Add a discount card. GoodRx, RxSaver, and Mark Cuban's Cost Plus Drugs list generic micronized progesterone at $10, $30 per 30-day supply at participating Illinois pharmacies. These prices are not insurance and cannot be combined with an insurance claim, but they often beat Tier 1 copays.

Step 3. Use a 503A compounder if you have a documented clinical need. Licensed Illinois compounders charge $25, $35/month. Do not choose compounding solely for cost if the FDA-approved generic is available and tolerated; use it when there is a clinical reason.

Step 4. Pursue insurance coverage with a PA if applicable. Illinois Medicaid with an approved PA reduces cost to $1, $4/fill. Commercial insurance Tier 1 generics run $10, $40/fill depending on the plan.

Step 5. Apply the AbbVie savings card for brand. Only relevant if your prescriber specifically writes for brand Prometrium and your commercial plan covers it; reduces copay to near zero but has no benefit for generic or Medicaid patients.

The Beers Criteria and ACOG guidelines both note that progesterone selection in postmenopausal women should weigh clinical benefit against cost and tolerability. Price alone should not drive the formulation decision, but there is no clinical reason to pay $180/month when a $10 generic delivers the same active molecule.

Drug Interactions, Side Effects, and Monitoring

Cost is one piece of the decision. Safety monitoring affects adherence and therefore total treatment cost over time.

Common Side Effects That Drive Discontinuation

Oral micronized progesterone causes somnolence in a significant minority of users, which is why bedtime dosing is standard. A controlled trial published in Fertility and Sterility found that 100 mg oral micronized progesterone produced measurable sedation compared to placebo. Women who cannot tolerate oral sedation may be switched to vaginal progesterone suppositories (which are also FDA-approved) or a compounded topical preparation, both of which alter the cost picture.

Key Drug Interactions

CYP3A4 inducers (rifampin, phenytoin, carbamazepine) reduce progesterone plasma levels. CYP3A4 inhibitors (ketoconazole, clarithromycin, grapefruit juice) may increase levels. The FDA label advises caution when combining Prometrium with known CYP3A4 inducers or inhibitors. Patients on these co-medications should have their progesterone levels checked 4 to 6 weeks after any dose change.

Monitoring Labs

Routine serum progesterone monitoring is not standard for oral HRT in postmenopausal women, though many clinicians check a trough level 4 to 6 weeks after initiation to confirm absorption. The Menopause Society (formerly NAMS) recommends annual re-evaluation of HRT indication, dose, and tolerability. Endometrial biopsy is indicated if breakthrough bleeding occurs on combined HRT.

A 2023 Menopause Society position statement on hormone therapy reinforces that micronized progesterone is the preferred progestogen for women with an intact uterus on systemic estrogen, with evidence supporting cardiovascular and breast safety advantages over synthetic progestins at approved doses.

Comparing Your Options: A Quick Reference Table

| Option | Typical Illinois Monthly Cost | Insurance Accepted? | FDA-Approved? | |---|---|---|---| | Brand Prometrium (AbbVie) | $180 list / $0, $90 with insurance | Yes | Yes | | Generic micronized progesterone (retail) | $38, $50 cash | Yes | Yes | | Generic + GoodRx/Cost Plus | $10, $30 | No (cash only) | Yes | | Illinois Medicaid (PA approved) | $1, $4 copay | Medicaid | Yes | | Compounded 503A (oral capsule) | $25, $35 | Rarely | No |

Who Should Not Take Prometrium

Before focusing on price, confirm candidacy. Prometrium is contraindicated in patients with: known or suspected breast cancer, undiagnosed abnormal uterine bleeding, active or prior thromboembolic disease, liver dysfunction or disease, known sensitivity to progesterone or peanut oil, and missed abortion. The full contraindication list is in the FDA prescribing information.

The Women's Health Initiative Memory Study (WHIMS) found a small but statistically significant increase in dementia risk with combined CEE plus MPA in women over age 65, though that study used medroxyprogesterone acetate, not micronized progesterone. The data cannot be extrapolated directly to Prometrium, but the finding reinforces the need for a personalized risk-benefit discussion before starting any HRT.